Valuation: Pfizer, Inc.

Market Cap 158B 141B 131B 120B 226B 15,259B 228B 1,591B 617B 7,781B 595B 582B 25,008B P/E 2026 *
17.5x
P/E 2027 * 13.6x
Enterprise Value 206B 183B 171B 156B 293B 19,831B 296B 2,068B 802B 10,113B 773B 756B 32,503B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.33x
Free-Float
59.05%
Yield 2026 *
6.19%
Yield 2027 * 6.24%
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 55 2026-08-15
Compliance Officer 65 2013-11-30
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-4.39% - - 158B
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.82%-3.39%+27.17%+57.15% 410.8B
Weighted average by Cap. -0.63%-3.33%+30.52%+68.96%

Financials

2026 *2027 *
Net sales 62.24B 55.32B 51.56B 47B 88.67B 5,993B 89.51B 625B 242B 3,056B 234B 229B 9,823B 59.88B 53.22B 49.61B 45.22B 85.31B 5,766B 86.12B 601B 233B 2,940B 225B 220B 9,451B
Net income 8.9B 7.91B 7.37B 6.72B 12.68B 857B 12.8B 89.38B 34.64B 437B 33.41B 32.69B 1,405B 11.08B 9.85B 9.18B 8.37B 15.79B 1,067B 15.94B 111B 43.13B 544B 41.6B 40.7B 1,749B
Net Debt 47.48B 42.2B 39.34B 35.86B 67.65B 4,573B 68.29B 477B 185B 2,332B 178B 174B 7,494B 40.98B 36.42B 33.95B 30.95B 58.38B 3,946B 58.94B 412B 160B 2,012B 154B 151B 6,468B
Logo Pfizer, Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Trader
Investor
Global
Quality
ESG MSCI
A